Coxsackievirus A13, strain G13

REFERENCE STRAIN


EVAg

Produced by
: IP
Shipping From
: Paris - FR

Product Description

Ref-SKU:
017V-03972
field isolate
Product Risk Group: 
Virus name: 
Strain: 

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
1 vial

In stock

1 000,00 €
(Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Special feature: 
GMO: 
No
Biosafety restrictions: 
This virus was isolated in South Africa when wild poliovirus strains were still circulating. Therefore, it is considered as a WPV/VDPV potentially infected material and must be handled in compliance with the WHO GUIDANCE FOR NON-POLIOVIRUS FACILITIES TO MINIMIZE RISK OF SAMPLE COLLECTIONS POTENTIALLY INFECTIOUS FOR POLIOVIRUSES available at http://polioeradication.org/polio-today/preparing-for-a-polio-free-world/containment/containment-resources/.
Virus host type: 
Previous Name or Taxonomy: 
Infectivity Test: 
TCID50/ml on HEp2c cells
Viral titer: 
10e7.6 TCID50/ml
Production cell line: 
Virus Cultivability: 
Shipping conditions: 
IATA Classification: 

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Sunday, 1 January, 1950
Country of collection: 
Suspected epidemiological origin :